Literature DB >> 18418730

Growth inhibition induced by transforming growth factor-beta1 in human oral squamous cell carcinoma.

Xiumei Wang1, Wenjing Sun, Jing Bai, Linlin Ma, Yang Yu, Jingshu Geng, Jiping Qi, Zhongcheng Shi, Songbin Fu.   

Abstract

Oral squamous cell carcinoma (OSCC) is a world-wide health problem and its incidence accounts for 1.9-3.5% of all malignant tumors. Transforming growth factor beta/Smads (TGF-beta/Smads) signaling pathway plays an important role in oncogenesis, but its function and molecular mechanisms in OSCC remain unclear. Expression of transforming growth factor-beta receptor type II (TbetaRII) and Smad4 was studied by immunohistochemistry in 108 OSCC patients and 10 normal controls. Function and molecular mechanisms of TGF-beta/Smads signaling pathway was then investigated in two human tongue squamous carcinoma cell lines with high and low metastasis (Tb and Tca8113) by RT-PCR, Western Blot, immunofluorescence, cell growth curve and flow cytometry (FCM), respectively. TbetaRII and Smad4 were significantly down-regulated in tumor tissues (with or without lymph node metastasis) compared to normal oral epithelium tissues (P < 0.05). TGF-beta1 induced arrest of the cell cycle rather than cell death in Tca8113 and Tb cells, and this influence was mediated by the increasing the expression and changing the location of its downstream components of TGF-beta1/Smads signaling pathway. TGF-beta1 rapidly increased the expression of p15 and p21 in both Tca8113 and Tb cells. TGF-beta1 did not increase p27 expression in Tca8113 cells, but p27 expression was increased in Tb cells. These indicated that TGF-beta1 induced G(1) arrest of cell cycle through a different regulating pathway in Tb cells compared with Tca8113 cells. Thus, we conclude that TGF-beta/Smads signaling pathway play a important role on cell growth and metastasis potential in OSCC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18418730     DOI: 10.1007/s11033-008-9256-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  25 in total

1.  Targeted disruption in murine cells reveals variable requirement for Smad4 in transforming growth factor beta-related signaling.

Authors:  C Sirard; S Kim; C Mirtsos; P Tadich; P A Hoodless; A Itié; R Maxson; J L Wrana; T W Mak
Journal:  J Biol Chem       Date:  2000-01-21       Impact factor: 5.157

Review 2.  Smads: transcriptional activators of TGF-beta responses.

Authors:  R Derynck; Y Zhang; X H Feng
Journal:  Cell       Date:  1998-12-11       Impact factor: 41.582

3.  Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line.

Authors:  S P Fink; S E Swinler; J D Lutterbaugh; J Massagué; S Thiagalingam; K W Kinzler; B Vogelstein; J K Willson; S Markowitz
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

4.  Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.

Authors:  Bailu Peng; Jason B Fleming; Tara Breslin; Ana M Grau; Shuichi Fojioka; James L Abbruzzese; Douglas B Evans; Dan Ayers; Kyle Wathen; Tianai Wu; Kimberly D Robertson; Paul J Chiao
Journal:  Clin Cancer Res       Date:  2002-11       Impact factor: 12.531

5.  Biological effects and binding properties of transforming growth factor-beta on human oral squamous cell carcinoma cells.

Authors:  H Ichijo; F Momose; K Miyazono
Journal:  Exp Cell Res       Date:  1990-04       Impact factor: 3.905

6.  Tumor suppressor gene Smad4/DPC4, its downstream target genes, and regulation of cell cycle.

Authors:  P J Chiao; K K Hunt; A M Grau; A Abramian; J Fleming; W Zhang; T Breslin; J L Abbruzzese; D B Evans
Journal:  Ann N Y Acad Sci       Date:  1999-06-30       Impact factor: 5.691

7.  TGF-beta inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest.

Authors:  C Petritsch; H Beug; A Balmain; M Oft
Journal:  Genes Dev       Date:  2000-12-15       Impact factor: 11.361

8.  Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.

Authors:  Gayathri Subramanian; Roderich E Schwarz; Linda Higgins; Glenn McEnroe; Sarvajit Chakravarty; Sundeep Dugar; Michael Reiss
Journal:  Cancer Res       Date:  2004-08-01       Impact factor: 12.701

9.  [Transfection of the nm23-H1 gene into BcaCD885 cell line inhibits the potential of invasion, adhesion and mobility].

Authors:  Shao-wei Chen; Yu-ming Wen; Long-jiang Li; Jian Pan; Chang-mei Wang; Xiang-ling Liao
Journal:  Zhonghua Kou Qiang Yi Xue Za Zhi       Date:  2003-01

10.  Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus.

Authors:  Shoji Natsugoe; Che Xiangming; Masataka Matsumoto; Hiroshi Okumura; Saburo Nakashima; Hironori Sakita; Sumiya Ishigami; Masamichi Baba; Sonshin Takao; Takashi Aikou
Journal:  Clin Cancer Res       Date:  2002-06       Impact factor: 12.531

View more
  15 in total

Review 1.  Paradoxical roles of TGF-β signaling in suppressing and promoting squamous cell carcinoma.

Authors:  Fanglong Wu; Kelsey J Weigel; Hongmei Zhou; Xiao-Jing Wang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2018-01-01       Impact factor: 3.848

2.  Pioglitazone inhibits TGFβ induced keratocyte transformation to myofibroblast and extracellular matrix production.

Authors:  Hong-Wei Pan; Jin-Tang Xu; Jian-Su Chen
Journal:  Mol Biol Rep       Date:  2010-12-03       Impact factor: 2.316

3.  Targeting head and neck squamous cell carcinoma using a novel fusion toxin-diphtheria toxin/HN-1.

Authors:  Sirisha Potala; Rama S Verma
Journal:  Mol Biol Rep       Date:  2010-08-01       Impact factor: 2.316

Review 4.  Lessons learned from SMAD4 loss in squamous cell carcinomas.

Authors:  Ariel L Hernandez; Christian D Young; Jing H Wang; Xiao-Jing Wang
Journal:  Mol Carcinog       Date:  2019-05-29       Impact factor: 4.784

5.  Concerted loss of TGFβ-mediated proliferation control and E-cadherin disrupts epithelial homeostasis and causes oral squamous cell carcinoma.

Authors:  Thomas Andl; Grégoire F Le Bras; Nicole F Richards; Gillian L Allison; Holli A Loomans; M Kay Washington; Frank Revetta; Rebecca K Lee; Chase Taylor; Harold L Moses; Claudia D Andl
Journal:  Carcinogenesis       Date:  2014-09-18       Impact factor: 4.944

6.  Transforming growth factor-β regulates the growth of valve interstitial cells in vitro.

Authors:  Chen Li; Avrum I Gotlieb
Journal:  Am J Pathol       Date:  2011-08-16       Impact factor: 4.307

Review 7.  Two sides of the story? Smad4 loss in pancreatic cancer versus head-and-neck cancer.

Authors:  Stephen P Malkoski; Xiao-Jing Wang
Journal:  FEBS Lett       Date:  2012-02-03       Impact factor: 4.124

8.  QKI impairs self-renewal and tumorigenicity of oral cancer cells via repression of SOX2.

Authors:  Wei Lu; Feixue Feng; Jinke Xu; Xiaozhao Lu; Shan Wang; Lifeng Wang; Huanyu Lu; Mengying Wei; Guodong Yang; Li Wang; Zifan Lu; Yanpu Liu; Xiaoying Lei
Journal:  Cancer Biol Ther       Date:  2014-06-11       Impact factor: 4.742

9.  The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.

Authors:  Rong-Hui Xia; Xiao-Meng Song; Xiao-Jing Wang; Jiang Li; Li Mao
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

10.  Roles of TGFβ signaling Smads in squamous cell carcinoma.

Authors:  Gangwen Han; Xiao-Jing Wang
Journal:  Cell Biosci       Date:  2011-12-28       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.